Title |
Sustainability of High-Level Isolation Capabilities among US Ebola Treatment Centers
|
---|---|
Published in |
Emerging Infectious Diseases, June 2017
|
DOI | 10.3201/eid2306.170062 |
Pubmed ID | |
Authors |
Jocelyn J. Herstein, Paul D. Biddinger, Shawn G. Gibbs, Aurora B. Le, Katelyn C. Jelden, Angela L. Hewlett, John J. Lowe |
Abstract |
To identify barriers to maintaining and applying capabilities of US high-level isolation units (HLIUs) used during the Ebola virus disease outbreak, during 2016 we surveyed HLIUs. HLIUs identified sustainability challenges and reported the highly infectious diseases they would treat. HLIUs expended substantial resources in development but must strategize models of sustainability to maintain readiness. |
X Demographics
The data shown below were collected from the profiles of 16 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 8 | 50% |
United Kingdom | 2 | 13% |
Australia | 1 | 6% |
Venezuela, Bolivarian Republic of | 1 | 6% |
Unknown | 4 | 25% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 12 | 75% |
Scientists | 3 | 19% |
Science communicators (journalists, bloggers, editors) | 1 | 6% |
Mendeley readers
The data shown below were compiled from readership statistics for 18 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 18 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 3 | 17% |
Student > Bachelor | 2 | 11% |
Professor > Associate Professor | 2 | 11% |
Student > Ph. D. Student | 2 | 11% |
Other | 1 | 6% |
Other | 2 | 11% |
Unknown | 6 | 33% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 4 | 22% |
Medicine and Dentistry | 3 | 17% |
Engineering | 2 | 11% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 6% |
Nursing and Health Professions | 1 | 6% |
Other | 0 | 0% |
Unknown | 7 | 39% |
Attention Score in Context
This research output has an Altmetric Attention Score of 25. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 June 2019.
All research outputs
#1,329,817
of 23,150,406 outputs
Outputs from Emerging Infectious Diseases
#1,501
of 9,161 outputs
Outputs of similar age
#28,267
of 316,903 outputs
Outputs of similar age from Emerging Infectious Diseases
#29
of 118 outputs
Altmetric has tracked 23,150,406 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 9,161 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 43.9. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 316,903 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 118 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.